Cours Innovus Pharmaceuticals Inc Other OTC
Actions
US45778V1061
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+33,04% | 693 Md | |
+29,39% | 584 Md | |
-3,37% | 372 Md | |
+20,14% | 332 Md | |
+6,49% | 294 Md | |
+14,08% | 239 Md | |
-3,03% | 211 Md | |
+10,02% | 210 Md | |
+9,03% | 168 Md |